EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors

Matteo Lusardi iD, Cecilia Astigiano, Deianira Bellitto iD, Matteo Raineri iD, Giorgia Guccione iD, Annalisa Salis, Elena Cichero, Chiara Brullo iD, Marco Ponassi iD, Santina Bruzzone iD, Andrea Spallarossa iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70489 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Matteo Lusardi and 10 co-authors. Institution: Department of Pharmacy, Università degli Studi di Genova, Genova, Italy. Major MEDLINE topics: Sirtuin 2, Sirtuin 1, Thiourea, Drug Design. 53 references. The full text is freely available (open access, CC BY 4.0). Funded by: Università degli Studi di Genova, Ministero dell'Università e della Ricerca, Ministero della Salute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A series of pyrazolyl‐thioureas was designed and synthesized as novel sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) inhibitors. Compounds were prepared through a multistep, divergent procedure starting from amino pyrazole intermediates. Biological evaluation revealed that several derivatives exhibited significant SIRT2 inhibitory activity, with compounds 6a and 7f emerging as the most promising inhibitors, showing IC 50 values of 2.2 and 13.6 µM, respectively. Selected compounds displayed selective antiproliferative activity against HepG2 hepatocellular carcinoma cells, while showing limited cytotoxicity toward normal fibroblasts. The biological properties of 6a and 7f were further investigated by analyzing SIRT1 activity and correlating antiproliferative activity with tubulin acetylation. Docking simulations identified the molecular basis of SIRT1 and SIRT2 inhibition. Overall, these results identify pyrazolyl thioureas as a promising scaffold for novel SIRT1 and SIRT2 inhibitors with potential anticancer applications.

Subjects

MeSH terms (MEDLINE)

Sirtuin 2Sirtuin 1ThioureaDrug DesignPyrazolesAntineoplastic AgentsHistone Deacetylase InhibitorsHumansStructure-Activity RelationshipCell ProliferationMolecular Docking SimulationHep G2 CellsMolecular StructureDrug Screening Assays, AntitumorDose-Response Relationship, Drug

Author keywords

SIRT2 inhibitorsantiproliferative activitymolecular dockingpyrazolyl thioureasstructure–activity relationship

Substances

Sirtuin 2Sirtuin 1ThioureaPyrazolesSIRT2 protein, humanAntineoplastic AgentsSIRT1 protein, humanHistone Deacetylase Inhibitors

Authors and institutions

  • Department of Pharmacy, Università degli Studi di Genova, Genova, Italy.
  • Department of Experimental Medicine, Università degli Studi di Genova, Genova, Italy.
  • AOM - IRCCS Ospedale Policlinico San Martino, Genova, Italy.

ORCID profiles: Matteo Lusardi, Deianira Bellitto, Matteo Raineri, Giorgia Guccione, Chiara Brullo, Marco Ponassi, Santina Bruzzone, Andrea Spallarossa

Funding

  • Università degli Studi di Genova
  • Ministero dell'Università e della Ricerca
  • Ministero della Salute
  • University of Genoa
  • Ministry for Universities and Research
  • Italian Ministry of Health

Cite

APA

Lusardi, M., Astigiano, C., Bellitto, D., Raineri, M., Guccione, G., Salis, A., Cichero, E., Brullo, C., Ponassi, M., Bruzzone, S., & Spallarossa, A. (2026). Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.70489

Vancouver

Lusardi M, Astigiano C, Bellitto D, Raineri M, Guccione G, Salis A, et al. Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors. ChemMedChem. 2026. doi:10.1002/cmdc.70489

BibTeX
@article{Lusardi2026,
  author = {Lusardi, Matteo and Astigiano, Cecilia and Bellitto, Deianira and Raineri, Matteo and Guccione, Giorgia and Salis, Annalisa and Cichero, Elena and Brullo, Chiara and Ponassi, Marco and Bruzzone, Santina and Spallarossa, Andrea},
  title = {Design, Synthesis, and Biological Evaluation of Pyrazolyl Thioureas (PTUs) as SIRT1 and SIRT2 Inhibitors},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70489}
}
Start for free →